Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced positive results from an exploratory Phase 2A study ...
As Australia’s obsession with tanning rages on, people are turning to nasal sprays as a ‘safer’ way to tan. Experts say there’s nothing safe about them.
Vistagen reports positive results from exploratory phase 2A study of PH284 in cancer cachexia: South San Francisco, California Thursday, January 16, 2025, 16:00 Hrs [IST] Vistagen ...
Dec. 9, 2024 — Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM) to accurately model a patient's response to CAR T cell therapy in real time.